Step 1: The key findings from the articles are that quaternary ammonium compounds (QACs) have shown effectiveness in combating MRSA, a drug-resistant bacteria. These compounds have a strong bactericidal effect against MRSA strains and can be used in various settings to prevent its spread.

Step 2: The methodologies used in the research included testing the effectiveness of QACs against MRSA in laboratory settings and clinical trials. Researchers also examined the mechanisms by which QACs disrupt the cell membranes of MRSA, leading to their bactericidal effect.

Step 3: The implications of these findings are significant in the fight against antibiotic-resistant bacteria like MRSA. QACs offer a promising solution for controlling MRSA infections in healthcare settings, reducing the risk of transmission and improving patient outcomes. Additionally, the understanding of how QACs work against MRSA can lead to the development of more effective antimicrobial agents in the future.

Step 4: In conclusion, research on quaternary ammonium compounds has shown their effectiveness in combating MRSA through bactericidal action. The methodologies used in these studies included testing in both laboratory and clinical settings to demonstrate their efficacy. The implications of these findings are profound, offering a potential solution to the challenge of antibiotic-resistant bacteria like MRSA and paving the way for the development of more advanced antimicrobial agents.